PAT Therapist TrainingThe Psychedelic Consultancy | Newcastle, 21–24 August 2026
Designed for clinicians preparing to work within Australia's Authorised Prescriber (AP) scheme, this four-day training develops the core competencies required for safe and effective MDMA and psilocybin-assisted therapy, with a strong focus on translating knowledge into clinical application.
The program combines experiential breathwork, applied role plays, and case-based learning with practical guidance on integrating PAT into existing practice. This includes working within multidisciplinary teams, navigating clinic governance, managing challenging experiences, responding to adverse events, and working with emergent trauma material during and after dosing.
Suitable for psychiatrists, psychologists, therapists, and peer workers intending to work directly with patients.
Your Facilitators
Dr Joe Starke is a psychiatrist and TGA-approved supervisor of Authorised Prescribers. Since treatments commenced in 2023, Joe has supervised approximately a quarter of Australia's APs and brings extensive clinical experience delivering MDMA and psilocybin-assisted therapy in outpatient settings, alongside trial experience with 5-MeO-DMT and psilocin.
Monica Schweickle is a clinical psychologist and trauma therapist with over 20 years of experience. A Psychology Board Approved Supervisor, EMDR Consultant, and Co-Chair of the AAPi Psychedelic-Assisted Therapy Interest Group, Monica led the development of Australia's first clinical PAT clinic before co-founding The Psychedelic Consultancy. She has delivered over 40 psilocybin and MDMA-assisted therapy sessions under the AP scheme and has supported more than half of Australia's prescribers with clinical protocols, governance, and implementation.
Daniel Zalcberg is a registered psychologist (clinical registrar) and founder of The Life Medicine Collective. Dan's approach blends evidence-based therapies with depth-oriented and transpersonal frameworks, drawing on over 15 years of clinical training and personal exploration, including Buddhist and Jungian psychology, breathwork, shadow work, and a decade of learning from his Cocama and Asháninka teachers in the Peruvian Amazon. His work supports clients in moving toward insight, embodiment, and authentic self-expression.
Dr. Bianca Sebben is a clinical psychologist and co-founder of Indigenous Psychedelic Assisted Therapies (IPAT), an organisation advancing the centring of Indigenous knowledge in the PAT field. Bianca specialises in complex trauma, dissociative disorders, and working with Aboriginal and Torres Strait Islander peoples. She was a therapist on a psilocybin-assisted therapy trial for prolonged grief, holds an interest in 5-MeO-DMT, and provides training and supervision to PAT therapists in integration support and working with challenging experiences.
Dr Simon Amar is a consultant psychiatrist with extensive expertise in psychotherapy and psychedelic-assisted therapy. Trained at McGill University in Montreal, he joined MAPS in 2016 as a Principal Investigator, establishing the Montreal site for the Phase 3 MDMA-assisted psychotherapy trial for PTSD. After relocating to Melbourne in 2021, he joined the Psychedelic Research Lab at Monash University, contributing as a core therapist to clinical trials involving psilocybin, MDMA, and 5-MeO-DMT. He continues to supervise and mentor Authorised Prescribers and therapists across Australia.
Investment: $3,500 + GST Location: The Base Health and Community, Newcastle Dates: 21–24 August 2026